DziadzkoVClavelMADziadzkoM, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet2018; 391: 960–969.
2.
SanninoASmithRLIISchiattarellaGG, et al. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol2017; 2: 1130–1139.
3.
StoneGWLindenfeldJAbrahamWT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med2018; 379: 2307–2318.
4.
DefermSBertrandPBVerbruggeFH, et al. Atrial functional mitral regurgitation: JACC Review Topic of the Week. J Am Coll Cardiol2019; 73: 2465–2476.
5.
AsgarAWMackMJStoneGW.Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol2015; 65: 1231–1248.
6.
ObadiaJFMessika-ZeitounDLeurentG, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med2018; 379: 2297–2306.
7.
SatoHCavalcanteJLBaeR, et al. Coaptation reserve predicts optimal reduction in mitral regurgitation and long-term survival with transcatheter edge-to-edge repair. Circ Cardiovasc Interv2022; 15: e011562.
8.
ErrthumRCaballeroAMcKayR, et al. Comparative computational analysis of PASCAL and MitraClip implantation in a patient-specific functional mitral regurgitation model. Comput Biol Med2021; 136: 104767.
9.
GeisNASchlegelPHeckmannMB, et al. One-year results following PASCAL-based or MitraClip-based mitral valve transcatheter edge-to-edge repair. ESC Heart Fail2022; 9: 853–865.
10.
LimDSKarSSpargiasK, et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP Study. JACC Cardiovasc Interv2019; 12: 1369–1378.
11.
GrayburnPASanninoAPackerM.Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging2019; 12: 353–362.
12.
EggebrechtHSchelleSPulsM, et al. Risk and outcomes of complications during and after MitraClip implantation: experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheter Cardiovasc Interv2015; 86: 728–735.
13.
NingyanWKeongYK.Percutaneous edge-to-edge mitral valve repair for functional mitral regurgitation. Int J Heart Fail2022; 4: 55-74.
14.
SatoHCavalcanteJLBaeR, et al. Hemodynamic profiles and clinical response to transcatheter mitral repair. JACC Cardiovasc Interv2022; 15: 1697–1707.
15.
GrayburnPASanninoACohenDJ, et al. Predictors of clinical response to transcatheter reduction of secondary mitral regurgitation: the COAPT Trial. J Am Coll Cardiol2020; 76: 1007–1014.
16.
SodhiNAschFMRufT, et al. Clinical outcomes with transcatheter edge-to-edge repair in atrial functional MR from the EXPAND Study. JACC Cardiovasc Interv2022; 15: 1723–1730.
17.
RogersJH. Expanding the spectrum of TEER suitability: evidence from the EXPAND G4 post approval study. In: TCT2022, Boston, MA, 17-19 September 2022. New York: CRF.
18.
StoneGWAbrahamWTLindenfeldJ, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med. Epub ahead of print 05 March 2023. DOI: 10.1056/NEJMoa2300213.
19.
DziadzkoVDziadzkoMMedina-InojosaJR, et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J2019; 40: 2194–2202.
20.
DoldiPStolzLOrbanM, et al. Transcatheter mitral valve repair in patients with atrial functional mitral regurgitation. JACC Cardiovasc Imaging2022; 15: 1843–1851.
21.
BonowROO’GaraPTAdamsDH, et al. 2020 focused update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol2020; 75: 2236–2270.
22.
OttoCMNishimuraRABonowRO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol2021; 77: e25–e197.
23.
YoonSHMakarMKarS, et al. Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling. JACC Cardiovasc Interv2022; 15: 1711–1722.
24.
IzumiCEishiKAshiharaK, et al. JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease. Circ J2020; 84: 2037–2119.
25.
FarhanSSilbigerJJHalperinJL, et al. Pathophysiology, echocardiographic diagnosis, and treatment of atrial functional mitral regurgitation: JACC State-of-the-Art Review. J Am Coll Cardiol2022; 80: 2314–2330.
26.
Martinez-GomezEMcInerneyATirado-ConteG, et al. Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: a systematic review. Catheter Cardiovasc Interv2021; 98: E617–E625.
27.
EngströmAEVisMMBoumaBJ, et al. Mitral regurgitation is an independent predictor of 1-year mortality in ST-elevation myocardial infarction patients presenting in cardiogenic shock on admission. Acute Card Care2010; 12: 51–57.
28.
ThompsonCRBullerCESleeperLA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?J Am Coll Cardiol2000; 36: 1104–1109.
29.
NishinoSWatanabeNKimuraT, et al. The course of ischemic mitral regurgitation in acute myocardial infarction after primary percutaneous coronary intervention: from emergency room to long-term follow-up. Circ Cardiovasc Imaging2016; 9: e004841.
30.
MentiasARazaMQBarakatAF, et al. Prognostic significance of ischemic mitral regurgitation on outcomes in acute ST-elevation myocardial infarction managed by primary percutaneous coronary intervention. Am J Cardiol2017; 119: 20–26.
31.
FlintKBriekeAWiktorD, et al. Percutaneous edge-to-edge mitral valve repair may rescue select patients in cardiogenic shock: findings from a single center case series. Catheter Cardiovasc Interv2019; 94: E82–E87.
32.
HabermanDEstévez-LoureiroRBenito-GonzalezT, et al. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction. Eur Heart J2022; 43: 641–650.
33.
TangGHLEstevez-LoureiroRYuY, et al. Survival following edge-to-edge transcatheter mitral valve repair in patients with cardiogenic shock: a nationwide analysis. J Am Heart Assoc2021; 10: e019882.
34.
SimardTVemulapalliSJungRG, et al. Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation and cardiogenic shock. J Am Coll Cardiol2022; 80: 2072–2084.
35.
GodinoCMunafòAScottiA, et al. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry. J Heart Lung Transplant2020; 39: 1353–1362.
36.
AdamoMCurelloSChiariE, et al. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: a single centre experience. Int J Cardiol2017; 234: 53–57.
37.
Estevez-LoureiroRAdamoMArzamendiD, et al. Transcatheter mitral valve repair in patients with acute myocardial infarction: insights from the European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI). EuroIntervention2020; 15: 1248–1250.
38.
ParlowSDi SantoPJungRG, et al. Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - design and rationale of the CAPITAL MINOS trial. Am Heart J2022; 254: 81–87.
39.
MangieriAMelilloFMontaltoC, et al. Management and outcome of failed percutaneous edge-to-edge mitral valve plasty: insight from an international registry. JACC Cardiovasc Interv2022; 15: 411–422.
40.
AlessandriniHDreherAHarrC, et al. Clinical impact of intervention strategies after failed transcatheter mitral valve repair. EuroIntervention2021; 16: 1447–1454.
41.
MackMJLindenfeldJAbrahamWT, et al. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol2021; 77: 1029–1040.
42.
KanekoTHirjiSZaidS, et al. Mitral valve surgery after transcatheter edge-to-edge repair: mid-term outcomes from the CUTTING-EDGE International Registry. JACC Cardiovasc Interv2021; 14: 2010–2021.
43.
ChiaritoMPagnesiMMartinoEA, et al. Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis. Heart2018; 104: 306–312.
44.
AlperiAGranadaJFBernierM, et al. Current status and future prospects of transcatheter mitral valve replacement: JACC State-of-the-Art Review. J Am Coll Cardiol2021; 77: 3058–3078.
45.
SorajjaPBaeRGösslM, et al. Complementary transcatheter therapy for mitral regurgitation. J Am Coll Cardiol2019; 73: 1103–1104.
46.
LiskoJCGreenbaumABGuytonRA, et al. Electrosurgical detachment of MitraClips from the anterior mitral leaflet prior to transcatheter mitral valve implantation. JACC Cardiovasc Interv2020; 13: 2361–2370.
47.
BapatVRajagopalVMeduriC, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol2018; 71: 12–21.
48.
MullerDWMSorajjaPDuncanA, et al. 2-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation. J Am Coll Cardiol2021; 78: 1847–1859.
49.
MaisanoFTorraccaLOppizziM, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg1998; 13: 240–246.
50.
MaisanoFLa CannaGColomboA, et al. The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique. J Am Coll Cardiol2011; 58: 2174–2182.
51.
AliMShreenivasSSPrattDN, et al. Percutaneous interventions for secondary mitral regurgitation. Circ Cardiovasc Interv2020; 13: e008998.
52.
NickenigGHammerstinglCSchuelerR, et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the Cardioband percutaneous mitral repair system. JACC Cardiovasc Interv2016; 9: 2039–2047.
53.
Ferrero GuadagnoliADe CarloCMaisanoF, et al. Cardioband system as a treatment for functional mitral regurgitation. Expert Rev Med Devices2018; 15: 415–421.
54.
SchuelerRNickenigG.The Mitralign: strategies for optimal patient selection and optimised results. EuroIntervention2016; 12: Y67–Y69.
55.
WitteKKLipieckiJSiminiakT, et al. The REDUCE FMR Trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail2019; 7: 945-955.
56.
RogersJHBoydWDSmithTWR, et al. Combined MitraClip edge-to-edge repair with Millipede IRIS mitral annuloplasty. JACC Cardiovasc Interv2018; 11: 323–324.
57.
LatibAAnconaMBFerriL, et al. Percutaneous direct annuloplasty with Cardioband to treat recurrent mitral regurgitation after MitraClip implantation. JACC Cardiovasc Interv2016; 9: e191-e192.
